|
Name of the Subsidiary |
Date from which it became Subsidiary |
|
Lupin Pharmaceuticals Inc., U.S.A.
|
30.06.2003 |
|
Kyowa Pharmaceutical Industry Co. Ltd., Japan |
18.10.2007 |
|
Lupin Australia Pty Ltd., Australia |
01.12.2004 |
|
Lupin Holdings B.V., Netherlands |
30.03.2007 |
|
Pharma Dynamics ( Proprietary) Ltd., South Africa |
01.03.2008 |
|
Hormosan Pharma GmbH, Germany |
25.07.2008 |
|
Multicare Pharmaceuticals Philippines, Inc., Philippines |
26.03.2009 |
|
Lupin Atlantis Holdings SA, Switzerland
|
05.06.2007 |
|
Lupin (Europe) Ltd., U.K. |
05.06.2009 |
|
Amel Touhoku, Japan |
18.10.2007 |
|
Lupin Pharma Canada Ltd., Canada |
18.06.2009 |
|
Lupin Mexico SA de CV, Mexico |
23.08.2010 |
|
Generic Health Pty Ltd., Australia |
27.09.2010 |
|
Bellwether Pharma Pty Ltd., Australia |
27.09.2010 |
|
Max Pharma Pty Ltd., Australia |
27.09.2010 |
|
Lupin Philippines Inc., Philippines |
20.12.2010 |
|
Lupin Healthcare Ltd., India |
17.03.2011 |
|
Generic Health SDN. BHD., Malaysia |
18.05.2011 |
|
Generic Health SDN. BHD., Malaysia |
18.05.2011 |
| I’rom Pharmaceutical Co. Ltd., Japan |
30.11.2011 |
